Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumors

What is the purpose of this trial?

The purpose of this study is to determine whether accelerated BEP chemotherapy is more effective than standard BEP chemotherapy in males with intermediate and poor-risk metastatic germ cell tumors.



Children's Oncology Group (The)

Start Date: 01/17/2019

End Date: 02/01/2022

Last Updated: 01/18/2019

Study HIC#: 2000023877

Get Involved

For more information about this study, contact:
Sharon Huie
sharon.huie@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image